Anesthesia Experience in a Patient with Myotonia Congenita
Journal Title: Bagcilar Medical Bulletin - Year 2019, Vol 4, Issue 2
Abstract
Myotonia congenita (MC) was first described as a skeletal muscle disorder by Thomsen in 1876. As a result of the mutation of the chloride channel gene (CLCN1), which is on the 17th chromosome, patients suffer from muscle contractility and fatigue. Malignant hyperthermia may occur in these patients in anesthesia. We presented our anesthesia experience in a patient who suffers from MC in this article.
Authors and Affiliations
Yeşim Cokay Abut, Serkan Şimşek, Seher Köse, Şenay Kırgezen, Kübra Bolat, Veysel Erden
Keywords
Related Articles
- EP ID EP48056
- DOI 10.4274/BMB.galenos.2019.28989
- Views 258
- Downloads 0
Co-occurrence of Chiari Type 1 Malformation, Syringomyelia, Anterior Thoracic Meningocele And Neurofibromatosis Type 1: A Very Rare Case Report
Background: Neurofibromatosis type 1 (NF-1) is an autosomal dominant hereditary disease associated with neurological and skeletal dysplasias. It is known that anterior thoracic meningocele, which is a rare pathology, may...
Interleukin-6 Levels in the Cervicovaginal Fluid of Pregnant Women and Its Predictive Value in Preterm Delivery
Objective: The aim of this study was to determine interleukin (IL)-6 levels in the cervicovaginal fluid of pregnant women and its value in predicting preterm delivery. Method: One hundred and eleven pregnant women were...
Evaluation of Readmitted Patients After Intensive Care Unit Discharge (Retrospective Study)
Objective: Nearly %10 of the discharged patients are readmitted to intensive care unit (ICU) at the same hospital stay. Reduction of readmission rates could be used as a hospital performance indicator. Our aim is to anal...
Expanding Intensive Care Unit Management for Critically Ill Patients During COVID-19 Pandemic
No Abstract
Changing Trends and Experience with Esophageal Cancer Surgery in a Single University Hospital: Are The Results Similar or Not?
Objective: The main treatment modality for esophageal cancer remains to be surgery. Over the last decades, surgical strategies have evolved remarkably. When neoadjuvant chemoradiotherapy became standard, discussions abou...